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Cell adhesion and protein adsorption studies of 3D printed 
photopolymers
Richard M. Lee1, 2, Maryam Alband2, Matthew Penny2, 
Stephen T. Hilton2, Steve Brocchini1, 2, Peng T. Khaw1. 1National 
Institute for Health Research (NIHR) Biomedical Research Centre at 
Moorfields Eye Hospital NHS Foundation Trust and UCL Institute 
of Ophthalmology, London, United Kingdom; 2UCL School of 
Pharmacy, London, United Kingdom.
Purpose: 3D printing technology has the potential to develop 
personalised ophthalmic devices or organs with improved cost 
effectiveness and productivity. Limited experimental data exists 
as to the biocompatibility response of 3D printed photopolymers. 
We performed cell adhesion and protein adsorption studies of 3D 
printed photopolymers and materials used in current ophthalmic 
devices (Silicone, Polytetrafluoroethylene (PTFE) and Poly (methyl 
methacrylate) (PMMA)).
Methods: Poly(ethylene glycol) diacrylate (PEGDA) (Sigma, 
MO, USA) and proprietary photopolymer (‘Clear’ and ‘Flexible’ 
resin, FormLabs, MA, USA) sample discs (n=6, 5mm diameter) 
were developed using a high-resolution, desktop stereo-lithography 
(SLA) 3D printer (Form 1+, Formlabs). Materials used in current 
ophthalmic devices (Silicone, PTFE, PMMA) were punched out with 
similar dimensions to the 3D printed discs. Protein adsorption was 
quantified using fetal calf serum (Invitrogen, CA, USA) with a micro 
bicinchoninic acid (Micro BCA, ThermoFisher, MA, USA) protein 
assay kit and direct assessment of fluorescein-conjugated bovine 
serum albumin (FITC-BSA, Sigma) adsorption. Discs were seeded 
with monocytes and incubated for 24 hours at 37oC. Quantification 
of cell metabolism and cytotoxicity were performed using Alamar 
Blue and Live/Dead (ThermoFisher) assay kits respectively. Readings 
were recorded using a plate reader (Fluostar Optima, BMG Labtech, 
Buckinghamshire, UK). Data were compared using a two-tailed 
unpaired t-Test.
Results: 3D printed photopolymers demonstrated similar cell 
adhesion and protein adsorption compared to materials used in 
current ophthalmic devices. There were no statistically significant 
differences in measurements observed between 3D printed materials 
(P>0.05).
Conclusions: 3D printed photopolymer material demonstrated a 
similar biocompatibility response to currently used materials and may 
allow for the development of customisable ophthalmic devices or 
organs.
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Conjunctival tissue proteome demonstrates abnormal expression 
of wound response proteins in glaucoma patients
Hannu M. Uusitalo1, 2, Antti Jylhä1, Janika Nättinen1, 3, 
Anu Vaajanen2, Miihkali Härkönen2, Matti Nykter3, Lei Zhou4, 
Roger W. Beuerman1, 4. 1Ophthalmology, SILK, PPM, University of 
Tampere, Tampere, Finland; 2Tays Eye Center, Tampere University 
Hospital, Tampere, Finland; 3BioMediTech, University of Tampere, 
Tampere, Finland; 4SERI, Singapore, Singapore.
Purpose: Medically uncontrolled glaucoma is usually treated 
surgically. Postoperative scarring and fibrosis often occur as adverse 
outcomes requiring additional treatment and cause surgical failure. 
Using a novel proteomic analysis conjunctival health was evaluated 
in conjunctival specimens of glaucoma patients at the time of 
operation and compared to healthy conjunctiva.
Methods: Conjunctival tissues (1×2-5mm) were collected from 34 
glaucoma patients undergoing glaucoma surgery after long-term 
(2-21 years) use of topical antiglaucoma medication. Conjunctival 
tissues of 8 strabismus surgery patients were used as controls. 
Proteins derived from conjunctival tissues were analyzed for 
library generation using UniProtKB/SwissProt database. Relative 
quantification of protein expression levels in 4 μg of each biopsy 
sample was done by NanoLC-MSTripleTOF using SWATH 
acquisition. Statistical and MS data analysis were performed with 
extensive software by Sciex and David Bioinformatics.
Results: A protein identification library consisting of >1800 proteins 
(FDR 1 %) was established. In total >1550 proteins were identified 
and quantified in each sample. GO analysis of the conjunctiva 
proteome revealed 85 wound response associated proteins of which 
48 were differentially expressed (p≤0.05) between glaucoma and 
control patients. A number of proteins were under-expressed in 
glaucoma, such as complement factors (≥1.5 fold), fibrinogens (≥2 
fold) and serpinase family proteins (≥1.6 fold). Known tear fluid 
function-related proteins such as lysozyme decreased 2-fold and a 
plasma protein clusterin was up regulated 1.5-fold in conjunctival 
tissue from glaucoma patients.
Conclusions: Proteomic analysis of conjunctiva demonstrates protein 
profile of >1800 proteins and offers a powerful tool to further analyze 
processes like inflammation and wound healing in glaucoma patients 
who may be at risk from chronic use of glaucoma medications. It 
will also give an opportunity to further analyze the role of pathogenic 
mechanisms leading to failure in glaucoma surgery and to develop 
novel therapies for glaucoma patients.
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Collagen VIII and XI as Biomarkers for Post-operative 
Conjunctival Fibrosis
Tina T. Wong2, 3, Li Zhen Toh2, Stephanie Chu2, Jocelyn Chua1, 
Li Fong Seet2, 3. 1Singapore National Eye Centre, Singapore National 
Eye Centre, Singapore, Singapore; 2Ocular Therapeutics and Drug 
Delivery, Singapore Eye Research Institute, Singapore, Singapore; 
3Duke NUS Medical School, Singapore, Singapore.
Purpose: Collagen, in particular collagen I, is the major extracellular 
matrix responsible for the development and persistence of fibrosis. 
